Active-ingredient Dossier
Metoclopramide Hydrochloride Monohydrate
Active-ingredient Dossier for Metoclopramide Hydrochloride Monohydrate (antiemetic prokinetic agent). Australian brands, products, PBS listings, PBAC…
- Brand: APO-METOCLOPRAMIDE
- Brand: MAXOLON
- Brand: METOCLOPRAMIDE HCl
- Brand: PRAMIN
- Brand: METOCLOPRAMIDE
- Brand: METOMAX
- Therapeutic area: Gastroenterology
- Therapeutic area: Pain Management
What is
Metoclopramide Hydrochloride Monohydrate Metoclopramide Hydrochloride Monohydrate is an antiemetic prokinetic agent.
Australian brands containing
Metoclopramide Hydrochloride Monohydrate — APO-METOCLOPRAMIDE — MAXOLON — METOCLOPRAMIDE — METOCLOPRAMIDE HCl — METOMAX — PRAMIN — PIP-METOCLOPRAMIDE
Therapeutic areas
Metoclopramide Hydrochloride Monohydrate is registered in Infectious Disease (4 brands), Gastroenterology (1 brand), Oncology (1 brand), and Pain Management (1 brand).
Sponsor landscape
The ingredient is marketed by five sponsors: Arrotex Pharmaceuticals, Alphapharm, iNova Pharmaceuticals, Demogen Pharmaceuticals, and Medsurge Pharma.
PBS and regulatory activity
One brand containing Metoclopramide Hydrochloride Monohydrate has PBS-listed items, with the latest PBS schedule date of 1 May 2026.